Literature DB >> 24976199

Progressive multifocal leukoencephalopathy: a rare cause of cerebellar edema and atypical mass effect. A case report.

Chris Ojeda1, Rachid Assina2, Maureen Barry3, Ada Baisre4, Chirag Gandhi2.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is an opportunistic demyelinating disease of the CNS caused by the JC papovavirus (JCV). Demyelination due to oligodendrocyte death leads to multifocal, asymmetric lesions. MRI is a valuable tool for detecting and differentiating PML from other neuropathies. Radiographically, PML classically presents as bilateral, subcortical white matter lesions with a lack of brain atrophy. As the disease progresses, lesions become larger and coalesce to become confluent. Minor edema and mass effect are infrequently described and the presence of significant mass effect suggests an alternative diagnosis. In our case, a patient demonstrated atypical marked infratentorial mass effect. Bilaterally, cerebellar lesions with associated mass effect were observed, as well as effacement of cerebellar folia and partial effacement of the fourth ventricle. The diagnosis of PML was confirmed with a biopsy of the right cerebellar lesion showing classic PML histology, with JCV DNA detection by polymerase chain reaction in the biopsy material.

Entities:  

Keywords:  MRI; leukoencephalopathy; mass effect; progressive multifocal

Mesh:

Year:  2014        PMID: 24976199      PMCID: PMC4202899          DOI: 10.15274/NRJ-2014-10040

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  10 in total

Review 1.  Imaging manifestations of progressive multifocal leukoencephalopathy.

Authors:  R Shah; A K Bag; P R Chapman; J K Curé
Journal:  Clin Radiol       Date:  2010-06       Impact factor: 2.350

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 3.  Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.

Authors:  W Küker; I Mader; T Nägele; M Uhl; C Adolph; U Klose; U Herrlinger
Journal:  Eur J Neurol       Date:  2006-08       Impact factor: 6.089

4.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 5.  Progressive multifocal leukoencephalopathy.

Authors:  Robert Weissert
Journal:  J Neuroimmunol       Date:  2011-02       Impact factor: 3.478

6.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

Authors:  M M Thurnher; M J Post; A Rieger; C Kleibl-Popov; C Loewe; E Schindler
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

7.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

8.  Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy.

Authors:  D Karahalios; R Breit; M C Dal Canto; R M Levy
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-10

Review 9.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

10.  Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  J R Berger; L Mucke
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.